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Abstract 
In vitro evidence indicates that PGE2 production in renal 
medullary interstitial cells is stimulated by ADH and the PGE2 in¬ 
hibits the effect of this hormone on water transport. However, 
factors modulating renal production and excretion of PGE2 in states 
of altered water balance have not been well defined in vivo. There¬ 
fore, studies were designed to measure UpQE^V following endogenous 
ADH, exogenous ADH without dehydration, and dehydration without ADH 
using normal Sprague-Dawley (N) and Brattleboro (DI) rats. UpgE^ 
(Institut Pasteur). Urine was collected on ice because thin layer 
chromatography indicated that room temperature (24 hrs) resulted in 
conversion of 17% of PGE2 to PGA2. Stimulation of endogenous ADH by 
18 hr dehydration in N rats (U max 2673±132 mOsm/kg) increased 
UpGE2^ ^rom ?.9±0.7 to 11.2 ± 0.9 ng/12 hrs (p<0.05). Low dose vaso¬ 
pressin (600 mU/kg body wt/day) was given to DI rats for 7 days. By 
day one, UpQ^V increased from 6.9 ±3.6 to 29.3 ±4.7 ng/24 hrs (p<.005), 
while Uosm increased from 99±4 to 203 ±41 mOsm/kg. UPq£2V increased 
further on day 4 to 61 .4 ±9.2 ng/24 hrs (p<.005 compared to day 1) 
without further increase at day 7. The effect of dehydration in the 
absence of ADH was investigated in DI rats by collecting urine during 
the 4th through 16th hr of dehydration, while body wt decreased by 
5.7±0.6 (4th hr) to 15.5 ±1.0% (16th hr). Upg^V increased (p<.001) 
from 7.9 ±1.5 ng/12 hr at baseline to 23.3± 2.8 ng/12 hr during de¬ 
hydration with UQSm increasing from 103 ± 6 to 502 ±56 mOsm/kg. These 
studies demonstrate that in addition to ADH, dehydration alone is a 
potent stimulus to the renal productior and excretion of PGE2, an 
effect which may further modulate that action of ADH on the collecting 
duct. 
v 

Introduction 
The single most important factor influencing renal water 
metabolism is antidiuretic hormone. This peptide hormone is synthe¬ 
sized by cells in the supraoptic and paraventricular nuclei of the 
hypothalamus and stored in the posterior pituitary.^ Release of 
antidiuretic hormone is controlled primarily by plasma osmolalityJ58 
For plasma osmolality greater than 280 mOsmoles per kilogram water 
there is a positive linear correlation between plasma antidiuretic 
hormone concentration and plasma osmolal ity.^’ 128 yj^ function¬ 
al characteristics of the osmoreceptor in the anterior hypothalamus 
may be modified further by changes in circulating intravascular volume 
and pressure.^* 127 unlike the exquisite sensitivity of the osmore¬ 
ceptor to variations in solute concentration, substantial changes in 
volume are required to alter the release of antidiuretic hormone.^6 
Circulating antidiuretic hormone acts on renal collecting ducts 
and late segments of the distal convoluted tubule. Increased water 
permeability in isolated collecting tubules occurs only when the 
hormone is on the peritubular side of the cel Is.69> 70 Retrograde 
injection of vasopressin into the collecting system of rats produces 
no antidiuretic action.^8 
The basolateral plasma membranes of the collecting duct cells 
have a vasopressin specific receptor which is associated with an 
adenyl cyclase that catalyzes the formation of cyclic adenosine 
3', 5'-monophosphate (cyclic AMP) from adenosine 5'-triphosphate.25,126 
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Binding of vasopressin to the receptor activates the adenyl cyclase. 
The changes in water permeability after vasopressin stimulation are 
attributed to the increase in concentration of cyclic AMP.1^3 Ex- 
ogenous cyclic AMP mimics the actions of antidiuretic hormone. 
Methylxanthine inhibition of cyclic AMP-phosphodiesterase, the 
enzyme which catalyzes the breakdown of cyclic AMP, results in accumu¬ 
lation of endogenous cyclic AMP in renal tissue after vasopressin 
stimulation and increases the hydro-osmotic effect of the hormone.^9*^ 
Dousa and colleagues have proposed that the permeability of 
the luminal membrane is associated with a specific membrane protein 
which is a substrate for cyclic AMP-dependent protein kinase. Phos¬ 
phorylation of the protein leads to a change in membrane structure 
and increased water permeability.^2 Exposing rat renal medullary 
slices to vasopressin activates protein kinase.^ This activation is 
proportional to the concentration of cyclic AMP.^l The protein phos¬ 
phatase for dephosphorylation is also present in renal medulla; 
however, the subcellular localization of both the specific protein 
substrate for the vasopressin activated protein kinase and the 
specific protein phosphatase has not been determined. A causal re¬ 
lationship between this system and the vasopressin-induced changes 
in water permeability remains to be established as we11.^0* 134 
The cellular action of antidiuretic hormone requires the 
integrity of microtubules and microfilaments. Drugs like colchicine, 
vinblastine or podophyllotoxin which disrupt microtubules or prevent 
their assembly block vasopressin- or cyclic AMP-induced osmotic water 
flow without altering sodium transport in the toad urinary bladder.153 
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The antidiuretic action of vasopressin in vivo is also antagonized 
by these agents, but they had no effect on adenylate cyclase, cyclic 
AMP-phosphodiesterase, or cyclic AMP-dependent protein kinase from 
rat renal medulla.^2 These findings suggest a role for micro¬ 
tubules in mediating the action of vasopressin on the distal nephron 
and also that their involvement occurs after the cyclic AMP effects. 
Microfilaments are cytoplasmic organelles composed of protein 
with biochemical properties similar to muscle actinJ2 The micro¬ 
filaments terminate close to or may be directly attached to cell 
membranes.^ The antibiotic cytochalasin B which disrupts micro¬ 
filaments reversibly inhibits the hydro-osmotic effects of both 
vasopressin and exogenous cyclic AMP besides blunting the vasopressin- 
stimulated increase in endogenous cyclic AMP.37 
When toad urinary bladder is exposed to vasopressin the lateral 
intercellular spaces widen suggesting an intercellular pathway in 
transepithelial water flow.86’ 156 jf the toad bladder is first ex¬ 
posed to cytochalasin B and then to vasopressin striking morphologic 
changes occur. The most pronounced changes include accumulation of 
giant vacuoles intracellularly, cell swelling, and disruption of 
microfilaments along the basolateral membranes.87» 141 since the 
intercellular tight junctions are impermeable to water^S these 
studies suggest that microfilaments are involved in vasopressin- 
induced transcel1ular flux of water by altering properties of the 
basolateral plasma membranes. 
Other drugs also interfere with the cellular action of anti¬ 
diuretic hormone. Lithium impairs vasopressin-stimulated water 
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transport in the toad bladder in vitro and in rat and dog kidney in_ 
vivoJ^» 137 jhus, lithium produces a nephrogenic diabetes insipidus 
by impeding steps proximal and distal to cyclic AMP generation: both 
the vasopressin-stimulated adenylate cyclase and a cyclic AMP- 
dependent protein kinase are inhibited.^ 
Demeclocycline inhibits both vasopressin-induced and cyclic 
AMP-induced hydro-osmotic response of toad bladderJ52 Besides in¬ 
hibiting vasopressin-stimulated adenylate cyclase and cyclic AMP 
protein kinase in vitro,demeclocycline appears to cause nephro¬ 
genic diabetes insipidus at least in part by binding to a specific 
epithelial cell protein required for the action of antidiuretic 
hormone.^, ^1 » 136 
The sulfonylurea chlorpropamide causes increased release of 
endogenous antidiuretic hormone and potentiation of the renal 
action of submaximal doses of vasopressin.79» 112, 113 yhe drug has 
no effect on water flow in the absence of vasopressin^ 0r in the 
presence of maximal levels of the hormone.174 Paradoxically, chlor¬ 
propamide inhibits the effects of cyclic AMP on water transportT9* 
Early studies of drug-induced disorders of antidiuretic 
hormone action did not adequately investigate the possible role of 
naturally occurring substances which could modulate the renal response 
to antidiuretic hormone ijy vivo. For example, only recently have the 
prostaglandins been implicated in the mechanism of chlorpropamide- 
induced enhancement of vasopressin action.l75 yhe discovery of high 
concentrations of prostaglandin E2 and the enzymatic machinery for 
prostaglandin synthesis in renal medulla made it seem plausible that 
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prostaglandins have a function in modulating water excretion. 
Credit for the original description of the class of fatty 
acids now known as prostaglandins belongs to von EulerJ^Q it was 
not until twenty-five years later that Bergstrdm and Sjtivall succeeded 
in isolating these compounds^* ^ and elucidating their structures.^ 
The prostaglandins are twenty-carbon fatty acid derivatives of 
prostanoic acid (Figure 1). All the prostaglandins possess a C-15 
hydroxyl group and a C-l3:C-l4 trans double bond. The discrete 
classes -- E, F, A, B, C, and D -- are distinguished by the functional 
groups on the cyclopentane ring (Figure 2). The individual prosta¬ 
glandins differ further in the degree of unsaturation of the side 
chains, designated by the subscripts 1, 2, or 3. The termsaors 
refer to the configuration of the C-9 hydroxyl group, the a configura¬ 
tion being cis to the carboxyl function. 
Although recent evidence suggests that prostaglandin A290 and 
prostaglandin as Well as the related compounds thromboxane A2^5 
and prostacyclin^ are present in renal tissue, prostaglandin E2 and 
prostaglandin F2ct have long been considered the principal renal 
prostaglandins. 
The biosynthetic pathway for the renal prostaglandins is de¬ 
picted in Figure 3. The fatty acid precursor 5, 8, 11, 14-eicosa- 
tetraenoic acid (arachidonic acid) is released from the cellular 
phospholioid stores by phospholipase A. The conversion of arachi¬ 
donic acid into prostaglandins is catalyzed by prostaglandin synthe¬ 
tase in the presence of molecular oxygen. The synthetase a microsomal 
enzyme complex,27 consists of a cyclo-oxygenase, a peroxidase, and 
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an endoperoxide isomerase or reductase 
Briefly, arachidonic acid undergoes oxygenation and cycliza- 
tion in the presence of cyclo-oxygenase to form the endoperoxide 
intermediate prostaglandin G2. Prostaglandin G2, in turn, is con¬ 
verted to a second endoperoxide prostaglandin H2 via peroxidase. At 
this point, the biosynthetic pathway diverges to give prostacyclin, 
thromboxane A2, prostaglandin D2, prostaglandin F2a, or prostaglandin 
E2. Specifically, prostaglandin E2 is produced by the action of endo¬ 
peroxide isomerase on prostaglandin 
There is some evidence that other tissues have the enzymatic 
capability of converting prostaglandin E2 to prostaglandin A2-^4, ^2 
No studies have convincingly demonstrated prostaglandin E2 dehydro¬ 
genase in renal medullary tissue.24, 90, 149 whether the small 
amounts of prostaglandin A2 found by some workers is due to non- 
enzymatic dehydration of prostaglandin E2 to prostaglandin A23 and 
that prostaglandin 1S indeed an artifact of the isolation pro¬ 
cedures remains controversial.^’ 93 
Besides possessing the ability to synthesize prostaglandins, 
the kidney also has the capacity for their degradation. The enzymes 
responsible for prostaglandin E2 metabolism in the kidney include 
15-hydroxydehydrogenase (types I and II), a-13 reductase, and prosta¬ 
glandin E2-9-keto-reductase. 
The 15-hydroxydehydrogenases are both cytoplasmic enzymes.^ 
Type I uses NAD+ as a cofactor and is located primarily in the renal 
cortex. Type II is more abundant in renal medulla where its specific 
activity is twice that in cortex. NADP+ is the cofactor for the type 
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II dehydrogenase.96 
Prostaglandin E2 can be reversibly converted to prosta¬ 
glandin F2 by prostaglandin E2~9-ketoreductase, an NADP+-dependent 
soluble enzyme.95 There is interspecies variability in the distribution 
of the prostaglandin E2~9-keotreductase in the kidney^* 143 as wen 
as differences in the molecular properties of the enzymes from tissue 
to tissue.143 
The rat kidney also has a prostaglandin F2a-9-hydroxydehydro- 
genase.125 13, ]4-dihydro-15-keto-prostag1 and in F2ra can be dehy¬ 
drogenated via this enzyme to 13, 14-dihydro-15-keto-prostag1 and in E2, 
a urinary metabolite of prostaglandin E2. Hence, measurement of uri¬ 
nary metabolites of prostaglandin E2 may not be a reliable index of 
prostaglandin E2 metabolism. 
Although isolated reports suggest that prostaglandin E2 infused 
into the carotid artery inhibits water diuresis^ ancj that intra- 
cisternal prostaglandin results in increased plasma antidiuretic 
hormone activity,^ recent investigations have focused on the action 
of intrarenal prostaglandins to regulate vasopressin effects on water 
transport. 
Very early work was performed on the toad urinary bladder. 
Basal water transport in the toad bladder is not affected by prosta¬ 
glandin E].^ However, prostaglandin E-j uniformly antagonizes the 
permeability response of toad bladder to vasopressin and theophyl- 
line. ’ * In these experiments prostaglandin E] does not 
influence the hydro-osmotic effect of exogenous cyclic AMP.^» '23 
Polyphoretin phosphate, a competitive antagonist of prostaglandins. 
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but not indomethacin counteracts the toad bladder response to vaso- 
pressin in the presence of exogenous prostaglandin E-j. » In fact, 
in the absence of prostaglandins the competitive inhibitor exhibits a 
slight but measurable enhancement of vasopressin effects on water 
permeabilityJ24 Inhibition of endogenous prostaglandin E2 synthesis 
by indomethacin increases the osmotic water flow response to sub- 
maximal doses of vasopressin and cyclic AMP.65 
Intravenous infusion of prostaglandin E-j results in urinary 
excretion of the corresponding metabolites.6^ 74 Excretory clearance 
of intact prostaglandin from the circulation is negligible.6? Frolich 
and co-workers showed that unilateral renal artery infusion of the 
prostaglandin precursor sodium arachidonate or of angiotensin leads 
to an ipsilateral increase in urinary excretion of prostaglandin E 
as measured by competitive protein binding.62 
Though previous investigators found essentially no prosta¬ 
glandin E2 activity in extracts of rabbit renal cortex,^ Larsson and 
Anggard detected measurable amounts of prostaglandin E2 in cortex. 
However, these investigators confirmed that prostaglandin E2 bio¬ 
synthesis is ten times higher in the medullary region of the kidney 
compared to the cortex.92 More recently, evidence from stop-flow 
studies in dogs suggests that the site of entry of prostaglandin E 
into tubular fluid may be the loop of HenleJ66 It remains unclear 
if the bioassay utilized by Crowshaw and Szlyk was sensitive enough 
to detect the minute quantities of cortical prostaglandin E2. 
In microdissected slices of rabbit papilla, 39 to 42 percent 
of prostaglandin synthetase activity is associated with cells of the 
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collecting duct, but substantial activity remains in papillary slices 
lacking these cells.26 This finding is not in total agreement with 
previous histochemical data that localized prostaglandin synthetase 
exclusively to collecting ducts.22 By immunofluorescence tech¬ 
niques cyclo-oxygenase is found primarily in the collecting duct but 
also to a lesser extent in the interstitial cells of the renal medulla 
of the ratj26 Both renomedullary interstitial cells26 and collecting 
duct cells26 possess peroxidase activity. Whether this peroxidase 
is indeed the one involved in prostaglandin biosynthesis remains to 
be proven conclusively. 
Similar cytochemical studies have demonstrated 15-hydroxy- 
dehydrogenase in cells of the thick ascending limb and the distal 
1 I Q 
convoluted tubule in the cortex. In vitro prostaglandin E-j is 
concentrated by renal cortical slices with a tissue to medium ratio 
of up to six to one. No such uptake is exhibited by medulla.22 Thus, 
the prostaglandin E2 found in the cortex may in fact have been syn¬ 
thesized in the medulla and transported via tubular fluid to the 
cortex where it could be concentrated and then metabolized by the 
15-hydroxydehydrogenase. 
In the red hamster prostaglandin E-j does not inhibit renal 
adenyl cyclase activity directly but does antagonize the vasopressin- 
stimulated increase in the enzyme's activityJ66 Experiments with 
low concentrations of prostaglandin E] in rat rerial medulla corrobor¬ 
ate these findings.^ The permeability response of isolated perfused 
collecting tubules to vasopressin decreased approximately fifty per¬ 
cent in the presence of prostaglandin E], whereas tubules exposed to 
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prostaglandin E] alone displayed an increased water reabsorption.^ 
There is evidence that prostaglandin E diminishes the 
permeability of the collecting duct in vivo, hence producing a rise 
in free water clearance.^88 Inhibition of endogenous prostaglandin 
synthesis potentiates the peripheral action of vasopressin in con¬ 
scious dogs88 and in anesthetized hypohysectomized dogs undergoing a 
water diuresis.8 Prostaglandin inhibition may decrease medullary 
blood flow thereby enhancing the osmotic gradient for water reabsorp- 
OO 
tion. The in vitro potentiation of vasopressin by prostaglandin 
inhibition could be accounted for on this purely hemodynamic basis 
without altering the cellular action of vasopressin. However, 
indomethacin also potentiates the action of vasopressin in conscious 
rats in which renal hemodynamics did not changeJ82 Also, in renal 
papillae snap frozen in liquid nitrogen for cyclic AMP assay, the 
vasopressin-stimulated increase in cyclic AMP was enhanced after 
treatment with indomethacin^8* 1°2 -- further evidence to support the 
hypothesis that prostaglandins interfere with the cellular action of 
vasopressin to generate cyclic AMP. 
Infusion of prostaglandin E-j uniformly increases urine flow 
and free water clearance and decreases urine osmolality while renal 
blood flow and solute excretion simultaneously increase J8> ?2> 102,135, 151 
In agreement with these findings, water restricted dogs have diminished 
free water reabsorption after prostaglandin E] infusion into the renal 
artery.^2 These effects require the presence of endogenous anti- 
diuretic hormone.2^ Although an increase in the distal delivery of 
tubular fluid to the diluting segment of the nephron can account for 
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the increase in water excretion, this does not exclude the possibil¬ 
ity that prostaglandin E also inhibits the action of antidiuretic 
hormone on a cellular level. This hypothesis is substantiated by 
experiments showing that prostaglandin E-j administration results in a 
greater decrease in free water reabsorption and hypotonic urine than 
acetylcholine, a vasodilator, despite equivalent solute excretion in 
saline expanded dogsJ^^ Recently, Stygles and Hood have proposed 
that prostaglandin E2 antagonizes antidiuretic hormone by increasing 
intracellular free calcium ion which then results in disaggregation 
of the microtubular apparatus.^4 
Additional evidence that in situ prostaglandins play a role 
in the renal water transport mechanism is provided by experiments in 
which rabbit renomedullary interstitial cells grown in tissue culture 
synthesize prostaglandins 173 using this model system, Zusman 
and Keiser subsequently demonstrated that prostaglandin E2 biosynthe¬ 
sis is stimulated by the presence of vasopressinJ^4 Both vaso¬ 
pressin and dDAVP (1-desamino-8-d-arginine vasopressin) increased 
QQ 
rabbit urinary prostaglandin E2 excretion in vivo. 
Prostaglandins may also be involved in the maintenance of the 
medullary solute gradient. Rat renal papillary sodium concentration 
nearly doubles while chloride ion concentration increases sixty 
percent thirty minutes after treatment with prostaglandin synthetase 
inhibitors. Medullary plasma flow remains constant.^ Thus, prosta- 
glandins may modulate net renal water transport by this mechanism 
as wel1. 
Much work has been done to show that prostaglandins are in- 
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volved in regulating renal water transport via the peripheral action 
of antidiuretic hormone; however, some investigators maintain that 
many of the results can be explained on the basis of intrarenal 
hemodynamic changes produced by the prostaglandins.^ In vivo studies 
have been particularly complicated by variations in renal blood flow 
and renal vascular resistance which, in turn, may influence net water 
transport. In many instances it is unclear whether these hemodynamic 
changes are indeed the mechanism whereby prostaglandins exert their 
effects or the experimental conditions induced the changes in blood 
flow. For example, anesthetized acutely operated animals show a 
distinct decrease in renal blood flow after inhibition of prosta¬ 
glandin synthetase.^5 This decrease in renal blood flow can be 
blocked by prior treatment with sar^, ala^-angitensin II, an antagon- 
1 -50 
ist of angiotensin II. In contrast, conscious dogs given indo- 
148 
methacin have no change in basal renal blood flow. Thus stimula¬ 
tion of the animals can lead to release of angiotensin which in itself 
is known to increase renal prostaglandinsJ, ^ Norepinephrine has 
a similar effect. It is thought that experimental manipulation can 
potentiate the inhibitory actions of the prostaglandin synthetase 
l rr 
antagonists.1 
Prostaglandin E infusions also affect the distribution of 
renal blood flow. Increased renal blood flow is seen with prosta¬ 
glandin , prostaglandin E2, and arach:donic acid administration in 
dog^’ ^ and rat.^5 The magnitude of these vascular changes is more 
profound in the inner cortex than the outer cortex,^ but other vaso¬ 
dilators also show a preference for augmenting inner cortical blood 
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flow.142 It may be that prostaglandins mediate the effects of these 
vasodilators as well.^4 Conversely, with the inhibition of 
prostaglandin synthesis the attending decrease in renal blood flow 
is accompanied by redistribution of flow to outer cortical nephrons.88 
Solez and colleagues have measured a diminished medullary blood flow 
in rats after indomethacin treatment.*40 
Much of the information on renal prostaglandins and their role 
in renal physiology has been gained through in vitro studies, and 
other work has largely involved infusions of prostaglandin E^ which 
is not found in the kidney. The role of endogenous renal prosta¬ 
glandin E2 in mammalian systems in vivo has only recently been 
examined. Efforts in this area have largely been hindered by 
methodological problems in purifying and measuring the minute 
quantities of prostaglandins in physiological fluids. 
Numerous and diverse techniques have been developed for 
isolation and quantitation of prostaglandins: gas liquid 
chromatography-mass spectroscopy,0 competitive protein binding, 
isotope derivative methods,28 bioassay,^8 and radioimmunoassay.80 
Although gas liquid chromatography-mass spectroscopy is the most 
specific and accurate method available, it requires expensive 
equipment and most importantly lacks the sensitivity for measuring 
picogram quantities of prostaglandins in physiological fluids. 
Radioimmunoassay appears to be the most promising analytical 
tool at this time although there are several pitfalls. The 
sensitivity of radioimmunoassay is very high (to concentrations of 
five and ten picograms per milliliter); however, its specificity 
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may often fall short for certain applications. This has been a 
problem especially with regard to developing antisera to prostaglandins 
of the E series. Many investigators have attempted to prepare 
antibodies to the prostaglandin E's with variable 
success.44 ’ 80, 81, 82, 83, 131 Cross reactivity between prosta¬ 
glandin E^ and prostaglandin and between these prostaglandins 
and their metabolites31 has been the major impediment and is the 
reason radioimmunoassay tends to overestimate the amount of 
prostaglandin E. 
In addition, conjugation of prostaglandin E to the carrier 
protein via a reaction with carbodiimide results in significant 
quantities of prostaglandin B being formed; thus, the resultant 
antiserum possesses considerable affinity and cross reactivity with 
prostaglandin B.33 Some investigators have circumvented this 
problem by quantitatively converting prostaglandin E to prosta¬ 
glandin B in a controlled reaction and then assaying the mixture 
for prostaglandin B activity.131 
The development of a highly specific anti-prostaglandin E2 
antiserum at the Institut Pasteur44 enables picogram quantities 
of prostaglandin E2 in urine to be measured accurately after treatment 
of the urine with amber!ite33 and silicic acid column chromatography.31 
The objective of the present experiments was to establish 
a sensiti/e radioimmunoassay capable of measuring urinary prostaglandin 
excretion during water diuresis and antidiuresis in small rodents. 
The effects of temperature and time on the stability of prostaglandin E2 
in urine was examined to determine the ideal conditions for collection 

-15- 
and storage of urine prior to radioimmunoassay. Measurement of 
urinary prostaglandin E£ was determined following physiological 
stimulation of endogenous vasopressin in the Sprague-Dawley rat. 
Serial changes in urine osmolality and urinary prostaglandin 
excretion were also investigated in the Brattleboro strain of rats 
with congenital diabetes insipidus given physiological doses of 
exogenous vasopressin. The excretion of prostaglandin E? during 
dehydration in the absence of antidiuretic hormone was also investi¬ 
gated. These experiments were designed to determine the relationship 
between urinary excretion of prostaglandin E2 and the hydro-osmotic 
action of antidiuretic hormone. 

Methods and Materials 
Methods 
Effects of storage temperature and time on the stability of 
prostaglandin Eg in rat urine 
The effects of storage temperature and time on the conversion 
of urinary prostaglandin to prostaglandin were determined in 
thin layer chromatographic studies. Adequate urine volume for all 
studies was obtained from a 24-hour collection in a 253 gm 
Brattleboro rat with free access to water and standard ground Purina 
rat chow. 
The urine was partitioned into 1.0 ml fractions in 50 ml 
conical tubes. At time zero (tQ), approximately 30,000 cpm 
H-prostaglandin E2 in 10 yl ethanol were added to each sample and 
mixed thoroughly by vortex agitation. Samples were then assigned to 
one of three groups: room temperature (22° ± 3°C), standard 
refrigerator temperature (4°C), or freezer temperature (-20°C). 
After an interval of time (tn) measured from tg, varying from 
zero minutes to 14 days, each fraction was extracted with 8.0 ml 
ethyl acetate. Extraction of frozen urines was accomplished at the 
moment the samples had thawed completely. For these samples, tn 
equaled the time elapsed from tg to initiation of the thawing process. 
The ethyl acetate extract was evaporated under nitrogen at room 
temperature and the residue was dissolved in 500 yl ethyl acetate: 
methanol, 1:1, v:v. The concentrated extract was spotted on silica 
-16- 
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gel thin layer chromatography plates. As markers, duplicate standards 
containing 100 yg prostaglandin 200 yg prostaglandin E2 and 100 yg 
prostaglandin F2a ™ 300 y1 ethanol were spotted on peripheral channels 
of each plate. Each 20 cm x 20 cm plate accomodated six samples. 
To control for any ^H-prostaglandin ^ in the exogenous tracer 
that might interfere with the estimates of conversion of prosta¬ 
glandin E2 to prostaglandin A^, a 10 yl sample of ^H-prostaglandin E2 
in ethanol was plated directly (control #1). To demostrate that the 
method was capable of detecting conversion of prostaglandin E^ to 
prostaglandin A2, a second control (control #2) was prepared. A urine 
sample with 3H-prostaglandin E2 was titrated to pH 3 with 0.10 N 
hydrochloric acid prior to extraction and plating; this procedure is 
known to accelerate the conversion of prostaglandin E2 to prostaglan¬ 
din A2.3 
Each thin layer chromatography plate was developed twice in 
the same direction with chloroform:methanol:acetic acid:water, 
90:6:1:0.75, v:v:v:v. The prostaglandin markers were sprayed with 10% 
(w/v) phosphomolybdic acid in ethanol and visualized by dry heat. 
Zones with relative Rf's corresponding to the markers for prosta¬ 
glandin A2, prostaglandin E2, and prostaglandin F2a were scraped and 
vacuum aspirated into 6-inch Pasteur pipettes fitted with pyrex wool. 
The remaining areas of gel were treated similarly. The silica gel was 
eluted into scintillation vials with 6.0 ml methanol and samples were 
taken to dryness under air. To each vial was added 10 ml Aquasol and 
the samples were counted for five minutes. 
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Effects of endogenous antidiuretic hormone on urine osmolality 
and urinary excretion of prostaglandin E2 in the Sprague-Dawley rat 
Animals employed in these experiments were male Sprague-Dawley 
rats weighing between 255 gm and 275 gm. Rats were caged in pairs 
and allowed Purina rat chow and water ad 1ibitum until the beginning 
of the experiment. 
At the onset of an experiment, seven rats were weighed and 
placed into individual clean metabolic cages. The animals were 
allowed up to 20 gm per day of laboratory prepared food (470 gm 
sucrose, 300 gm casein, 100 gm lard, 50 gm corn oil, 24.4 gm NaCl, 
11.6 gm K2HPO4, and 50 gm vitamin-mineral mix) providing 8 milli- 
equivalents sodium per day. Free access to water was permitted. As 
prostaglandins are known to be involved in the mechanism of renin 
release,^8* 162, 163, 164 a controlled high sodium intake was utilized 
to maintain plasma renin at relatively steady low levels. 
On the eighth day, while continuing the stipulated diet 
each cage was equipped with a clean clamped funnel to collect all 
voided urine under mineral oil for 12 hours. At the inception of the 
urine collection the bladder of each rat was emptied by external 
massage and this urine was discarded. The procedure was repeated at 
the termination of the collection period and this urine combined with 
the volume accumulated in the metabolic funnel. Fecal contamination 
was prevented by interposing a fine mesh wire screen between the rat 
and the urine. Throughout the 12-hour period the amassed urine was 
kept at 0°C by immersing the funnels in ice-water baths replenished 
with ice every four to six hours as needed. After immediate deter- 
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mination of urine volumes, 7 ml aliquots of the specimens were frozen 
at -20°C for subsequent measurements of osmolality, creatinine, and 
prostaglandin E2- 
On the tenth day water was withdrawn from the rats. The 
animals were dehydrated for 30 hours. In order to obtain adequate 
urine during maximum stimulation of antidiuretic hormone secretion, 
urine was collected only between the 18th and 30th hours (12-hour 
collection). The collection procedure and handling of specimens 
were identical to that outlined above for the baseline determination. 
Effects of exogenous vasopressin on urine osmolality and 
urinary prostaglandin E? excretion in the Brattleboro rat 
Twelve 240 gm to 275 gm male Brattleboro rats which had 
previously been fed Purina rat chow pellets and water ad libitum 
were assigned to individual metabolic cages and allowed five days for 
acclimatization. During this time and the seven-day experimental 
period, the animals were offered water ad libitum and fed 15 gm ground 
Purina rat chow per day providing 1.5 milli-equivalents sodium per 
day. 
On day one and each day thereafter for seven days, a subcutaneous 
injection of vasopressin tannate in oil, 600 mU per kilogram body weight 
was administered. Exactly 24 hours after the initial injection, the 
second injection was given. The rats were immediately induced to 
void by external bladder massage and a 24-hour urine collection was 
begun. The procedure for collection and storage of urine was identical 
to that for the 12-hour collection detailed in the preceding section. 
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Similar 24-hour collections were completed on the fourth and seventh 
days of vasopressin administration. All rats were weighed at the 
beginning of the experiment and on the seventh day. 
Six hours after the final urine collection the animals were 
anesthetized with an intraperitoneal injection of Inactin, 100 mg 
per kilogram body weight. The inferior vena cava was surgically exposed 
and venous blood was collected into non-heparinized vacutainer tubes. 
The serum was stored at -20°C for subsequent creatinine determinations. 
Effects of dehydration alone on urine osmolality and 
urinary prostaglandin excretion in the Brattleboro rat 
Eleven male Brattleboro rats between 200 gm and 300 gm were 
caged in pairs and offered Purina rat chow pellets and water ad 
1ibitum. Five days prior to an experiment the rats were transferred 
to individual clean meatbolic cages and permitted to acclimate to 
the surroundings. During this time and the experimental period the 
animals were given 15 gm ground Purina rat chow per day and water 
ad libitum unless otherwise specified. 
On the sixth day the rats were weighed and a baseline 12-hour 
urine collection was performed as described earlier in this text. 
Volume measurements were done on samples which were then frozen 
at -20°C. 
The subsequent day the rats were weighed once again and water 
was withdrawn. After four hours dehydration, the animals' weights 
were checked and another 12-hour urine collection was executed. The 
rats continued to be deprived of water during the collection period. 
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At the end of 16 hours dehydration the rats were reweighed. Urine 
volumes were measured and the specimens were frozen at -20°C for later 
measurements of osmolality, creatinine and prostaglandin E2. 
The rats were anesthetized with Inactin as in the previous 
group and blood obtained for plasma creatinine. 
Quantitation of urinary prostaglandin E2 by radioimmunoassay 
On the day of assay for prostaglandin E2 the frozen urine 
specimens were thawed at room temperature. Then, 5.0 ml aliquots 
were immediately pipetted into individual 50 ml Nalgene screwcap 
centrifuge tubes. A 5.0 ml phosphosaline buffer blank and a control 
sample with 1.0 ng prostaglandin E2 in 5.0 ml phosphosaline buffer 
were treated similarly. 
For subsequent calculation of recovery, expressed as percent 
prostaglandin E, approximately 2000 cpm ^H-prostaglandin E^ in 50 yl 
ethanol were introduced into each sample and into duplicate 
scintillation vials for determination of total recovery. The tubes 
were vortexed. After each specimen had received 1.0 gm Amberlite CG-50, 
the tubes were placed at a 45 degree angle into a Dubnoff Mechnical 
shaker and agitated at the maximum setting (#9) for 20 minutes at room 
temperature. The tubes were then centrifuged at 5000 g for 10 minutes 
at 4°C, and the aqueous supernatant was aspirated and discarded. 
Elution of prostaglandins from the resin was accomplished by two 
washings (shaking 20 minutes at room temperature as above) with 5.0 ml 
methanol. Each extraction was followed by centrifugation as before. 
The organic phase was transferred to a 15 ml screwcap culture tube. 
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The combined methanol layers from the respective samples were dried 
under nitrogen at room temperature in an N-Evap for to a final volume 
of 1 ml to 3 ml. 
After acidification with 25 pi 1.0 N hydrochloric acid, ex¬ 
traction with 8.0 ml ethyl acetate, and centrifugation at 1000 g for 
10 minutes at 4°C, the top phase was pipetted into a clean 15 ml 
screwcap culture tube. The solvent was evaporated to dryness under 
nitrogen, and the residue was resuspended in 0.20 ml solvent IV 
(benzene:ethyl acetate:methanol, 60:40:10, v:v:v) and vortexed vigor¬ 
ously. Then 0.80 ml solvent I (benzene:ethyl acetate, 60:40, v:v) 
was added and the solution vortexed again. The prostaglandin solu¬ 
tions were capped and stored under nitrogen at -20°C overnight. 
Isolation and purification of the prostaglandins was carried 
out by silicic acid column cnromatography. One 16 cm x 1 cm Brock's 
mini-column with a piece of Whatman GF/A filter paper cut to fit the 
base with a #5 cork borer was set up for each separate sample. A 
slurry of 500 mg washed silicic acid in 5.0 ml solvent II (benzene: 
ethyl acetate:methanol, 60:40, v:v:v) was carefully transferred to 
the mini-columns by Pasteur pipette. When the solvent meniscus had 
reached the level of the silicic acid, the samples were applied to 
the columns. The fraction containing both prostaglandin A and 
prostaglandin B was eluted from the column with 4.0 ml solvent I and 
discarded. Next, 13.0 ml solvent II were utilized to elute the 
prostaglandin E; this fraction was collected in 20 ml screwcap vials. 
The solvent was evaporated to dryness under nitrogen, and the prosta¬ 
glandin E redissolved in 1.0 ml ethanol. 
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To assess recovery an 0.10 ml aliquot of this ethanolic 
solution was pipetted into 10 ml Aquasol in a scintillation vial 
and counted for ten minutes. Yield was expressed as percent of 
total recovery. 
The remainder of the prostaglandin E in ethanol was stored 
under nitrogen at -20°C until the time for quantitation of prosta¬ 
glandin E2 by radioimmunoassay the next day. 
Duplicate 0.10 ml aliquots of the prostaglandin E solutions 
were pipetted into 10 mm x 75 mm RTU culture tubes. An occasional 
sample required 0.20 ml aliquots in order to obtain a quantity of 
prostaglandin E2 within the range of the standard curve. A standard 
curve was pipetted from stock solutions (SS) of prostaglandin E2 in 
ethanol: SS 1 contained 10.0 ng prostaglandin E2 per 1.0 ml ethanol, 
SS 2 had 1.0 ng prostaglandin E2 per 1.0 ml ethanol. Appropriate 
volumes of the stock solutions were pipetted in duplicate to obtain 
eight values (SI to S8) ranging from 1 pg to 1 ng prostaglandin E2 
as shown in Table 1. Two tubes each for total counts (TC), non¬ 
specific binding (NSB), and initial binding (Bq) were also set up at 
this time. 
After complete evaporation of the ethanol in a vacuum over 
at 15 mm Hg at room temperature, 0.10 ml phosphosaline buffer with 
0.10% (w/v) gelatin was measured into each tube and vortexed. 
Ethanol in which the H-prostaglandin E^ was stored was evaporated 
under nitrogen and the -^-prostaglandin E2 was brought up in a volume 
of phosphosaline buffer with gelatin so that 0.10 ml phosphosaline 
buffer with gelatin would deliver approximately 10,000 cpm to each 
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sample. All samples were again vortexed. Into all except the TC 
and NSB tubes was pipetted 0.10 ml anti-prostaglandin E2 antiserum. 
The TC and NSB tubes received a second 0.10 ml phosphosaline buffer 
with gelatin without the antibody. After vortexing gently, the 
samples were allowed to stand at room temperature for exactly 10 
minutes from the time of addition of the antiserum. Then, the tubes 
were transferred to an ice bath for 2 hours. 
At the end of the reaction period, 1.0 ml dextran-coated 
charcoal solution was pipetted within 1 minute into all the samples 
except the TC tubes. Exactly 10 minutes later the samples were 
centrifuged at 2200 g for 10 minutes at 4°C. The supernatant was 
quantitatively decanted into individual scintillation vials already 
containing 15 ml Biofluor and 0.70 ml demineralized water. The vials 
were capped, vortexed and refrigerated until a clear homogeneous 
solution appeared at which time they were counted for 20 minutes. 
All values for urinary prostaglandin E2 were corrected for 
losses incurred through extraction and chromatography. In all the 
steps prior to radioimmunoassay prostaglandin E-j and prostaglandin E2 
are indistinguishable; therefore, yield was estimated as percent of 
•3 
total recovery of added H-prostaglandin Ej. 
The affinity, specificity, and sensitivity parameters of the 
Pasteur anti-prostaglandin E2 antiserum have been published.^ 
Because of the weak cross reactivity of the antiserum with prosta¬ 
glandin E-j (2.7%),^ no correction was made for the tracer amount of 
^H-prostaglandin E] added for recovery measurements. 
Percent of trace binding was calculated as the fraction of 
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initial binding (Bq). Both values were corrected for nonspecific 
binding (NSB); that is, 
% trace binding = x • NSB x 100 
Bq ”N5b 
where x is the binding of the standard or test sample. For standards 
the resulting values were plotted on a log-logit scale. Percent 
trace binding for the test samples was determined from the above 
equation and the amount of prostaglandin E2 read off the abscissa. 
For determination of quenching, duplicate scintillation vials 
o 
containing approximately 30,000 cpm °H-prostaglandin E2 were counted 
with 15 ml Biofluor alone and after the introduction of 0.70 ml 
demineralized water and 1.3 ml phosphosaline buffer with gelatin. 
Percent quenching was calculated from the formula 
cPm(Biofluor) - cpm(Biofluor:H?0:PSBG) 
^ = cPm(Biofluor) X 
Background was assessed as cpm for a Biofluor:water:phosphosaline 
buffer with gelatin mixture without tritiated prostaglandin. 
Materials 
Sprague-Dawley rats were ordered from Charles River (Boston, 
MA). Brattleboro rats were from the colony of Dr. John N. Forrest, 
Jr. 
Vasopressin tannate suspension 4n peanut oil for intramuscular 
injection was furnished by Park, Davis and Company (Detroit, MI). 
Inactin came from Hamburg, Germany. 
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Unlabel led prostaglandins for standards were generously 
supplied by Dr. John L. Pike of the Upjohn Company (Kalamazoo, MI). 
Tritiated prostaglandin E-j{( 5,6(n)-^H} -prostaglandin E], Code 
TRK.426, Batch 12) was a product of the Amersham Searle Corporation 
(Atlington Heights, IL). Tritiated prostaglandin E2, Lot 932 122) 
came from the New England Nuclear Company (Boston, MA). Both radio¬ 
active prostaglandins were purified by silicic acid column chromato¬ 
graphy (see methods) within two weeks of use. All prostaglandins 
were stored in ethanol under nitrogen at -20°C. 
Thin layer chromatography plates were prescored silica gel 
GF 250 v thick from New England Nuclear. 
In all cases ethanol was absolute ethyl alcohol purchased 
from U.S. Industrial Chemicals Company (New York, NY). Organic 
solvents were Mallinckrodt SpectrAR grade unless otherwise indicated 
and were used without further purification. Concentrated hydro¬ 
chloric acid 37% (w/v) was obtained from Mallinckrodt, Incorporated 
(St. Louis, MO). All water was demineralized by passage through a 
D 5041 mixed resin filter of the Barnstead Sybron Corporation. 
Sodium chloride (NaCl) and sodium hydroxide (NaOH) were 
reagent grade chemicals from Mallinckrodt. Sodium dihydrogen phos¬ 
phate Monohydrate (NaH2P04.HgO), reagent grade, came from Fischer 
Scientific Company (Fair Lawn, NJ). Practical grade sodium azide 
(Naf^) was provided by the Matheson, Coleman and Bell Manufacturing 
Chemists, Norwood, OH). Gelatin was obtained from Difco Laboratories 
(Detroit, MI). 
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Amberlite CG-50, 100 to 200 mesh, and silicic acid, 100 mesh, 
were products of Mai 1inckrodt. Prior to chromatography, silicic acid 
was washed three times with four volumes methanol to remove fines, 
dried in an oven at 40°C, and stored in a dessicator. 
Phosphosaline buffer consisting of 0.10 M phosphate and 0.90% 
(w/v) NaCl with 0.10% (w/v) NaNg as preservative was brought up to 
pH 7.40 with NaOH. On day of radioimmunoassay, phosphosaline buffer 
with 0.10% (w/v) gelatin was prepared by dissolving 1 mg gelatin per 
1 ml phosphosaline buffer over low heat and then cooling slowly to 
room temperature. 
Dextran-coated charcoal was made by combining 300 mg Norit A 
(Fischer Scientific Company) with 100 ml phosphosaline buffer with 
gelatin at 0°C on a magnetic stirrer. When the charcoal had become 
nomogeneously dispersed in buffer, 30 mg Dextran T 70, Pharmacia 
(Uppsala, Sweden) was added. The mixture was stirred continuously 
and kept at 0°C for 30 minutes before and during use. 
Anti-prostaglandin E^ antiserum (immunogenrprostaglandin E2- 
bovine serum albumin, animal: rabbit. Code 79 585 - Lot C) came in 
lyophylized form from Dr. F. Dray, Institut Pateur (Paris, France). 
The antiserum was stored at 4°C. At the time of assay the antibody 
was dissolved in 11.0 ml chilled phosphosaline buffer with gelatin 
and held at 0°C. 
All centrifugations took place in a Sorvall RC-2 centrifuge 
manufactured by the Dupont Company (Norwalk, CT). Speeds are noted 
for the respective experiments. 
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Osmolalities were measured by freezing point depression on an 
osmomete from Advanced Instruments, Incorporated (Needham Heights, 
MA). 
Evaporation under nitrogen was carried out on an N-Evap 
analytical evaporator by Organomation Associates, Incorporated 
(Shrewsbury, MA). 
Assessment of radioactivity was performed in a refrigerated 
(2°C) Packard Tri-Carb Liquid Scintillation Spectrometer Model 3320 
(Downers Grove, IL). Scintillation fluid was Aquasol or Biofluor 
as specified from New England Nuclear. Times for counts are indicated 
for each determination. 
Creatinine was measured employing a modification of the pro¬ 
cedure of Folin and Wu on an Autoanalyzer, Technicon Corporation 
(Chauncey, NY). 

Results 
Effects of storage temperature and time on the stability of prosta¬ 
glandin E? in rat urine 
The thin layer chromatography experiments were designed to assess 
the optimal temperature for timed urine collections and storage of 
specimens in order to minimize loss of prostaglandin E2 by conversion 
to prostaglandin A2. The proportion of conversion was examined at 
three temperatures: room temperature (22° ± 3°C), refrigerator 
temperature (4°C), and freezer temperature (-20°C). Since the parti¬ 
tion coefficient for extraction of prostaglandins from aqueous to 
organic media is pH dependent, urine of identical pH (pH 6.3) from a 
single urine collection was used in all thin layer chromatography 
experiments (except Control #2). The relative amounts of tritiated 
prostaglandin in the prostaglandin E2 and the prostaglandin ^ zones 
was calculated as the percent of total recovered radioactivity for 
the given sample and are listed in Table 2. 
After one hour, the radioactivity present in the prostaglandin k^ 
zone of samples at any of the three temperatures did not differ 
substantially from the amount of radioactivity detected in the 
prostaglandin A2 zone of Control #1 plated without processing through 
urine. The amounts of tracer found in the prostaglandin A2 zone at 
room temperature, 4°C and -20°C were 4%, 5% and 2% of total radio¬ 
activity, respectively. However, 4% of the tritiated prostaglandin 
in Control #1 was eluted from the prostaglandin zone. 
From Figure 4 it can be appreciated that samples kept at 4°C and 
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-20°C showed no change in the proportion of tracer converted to 
prostaglandin A2 after a lapse of 24 hours, but at room temperature 
■5 
17% of the added H-prostaglandin E2 was recovered from the prosta¬ 
glandin A2 zone. After 48 hours still no alteration in the distribu¬ 
tion of tracer was discernible in the samples at 4°C and -20°C; 
however, following two weeks at 4°C this specimen contained 20% of 
the recovered labeled prostaglandin in the prostaglandin A2 band. 
The percent of H-prostaglandin E2 recovered from the prostaglandin 
E2 zone of this sample concomitantly decreased to 20% whereas in 
previous specimens the percent tracer in the prostaglandin E2 band 
ranged from 65% to 36% (Table 2). Even after two weeks of storage 
at -2Q°C, the percent of tritiated prostaglandin in the prostaglandin 
A2 zone (3%) did not differ from that in Control #1 (4%). 
To evaluate the capability of thin layer chromatography to 
detect tracer amounts of prostaglandin A2 produced from prostaglandin 
E2 a positive control (Control #2) was prepared by adjusting the 
urine to pH 3 which is known to facilitate nonenzymatic conversion of 
3 
prostaglandin E2 to prostaglandin A2. After thus treating the 
samples, 23% (4°C) to 31% (RT) of the tritiated prostaglandin was 
eluted from the prostaglandin A2 zone; the 3H~prostaglandin E2 re¬ 
maining in the prostaglandin E2 band decreased to 36% (4°C) and 41% 
(RT). For both these controls tn equaled ten minutes. 
To avoid artifactually inducing conversion of prostaglandin 
E2 to prostaglandin A2 in the test urines none of these urines were 
acidified before extraction and plating. Hence, recovery of total 
inoculated JH-prostaglandin E2 after extraction, chromatography, and 
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elution varied over a wide range: 12.1% to 51.2%. 
Effects of endogenous antidiuretic hormone on urine osmolality and 
urinary excretion of prostaglandin E? in the Sprague-Dawley rat 
Dehydration of normal Sprague-Dawley rats was utilized to 
examine the effect of endogenous antidiuretic hormone secretion on 
urinary excretion of prostaglandin E2. Average body weights of the 
rats at the inception of the experiment was 265 ± 3 gm. After eight 
days of sodium loading body weight averaged 306 ± 4 gm, an increase 
of 13.6 ± 0.9%. 
As indicated in Table 3, urine flow during the 18th through 
30th hours of dehydration was 6.1 ± 0.4 pi per minute which was a 
significant decrease (p< 0.005) from the baseline value, 13 ± 1.4 pi 
per minute. Predictably, urinary osmolality increased from 1268 ± 70 
mQsm per kg at baseline to a maximum 2673 ± 132 mOsm per kg after de¬ 
hydration (p <0.001). Despite a marked reduction in urine flow, 12 
hour excretion of prostaglandin E2 increased from 7.9 ± 0.7 ng to 
11.2 ± 0.9 ng (p < 0.05). Urinary creatinine excretion did not 
change significantly with dehydration. 
Effects of exogenous vasopressin on urinary prostaglandin E2 excretion 
in the Brattleboro rat 
The effect of daily low dose exogenous vasopressin on renal 
water metabolism and excretion of prostaglandin E2 was observed over 
seven days. Table 4 shows the serial changes in urine flow, urinary 
osmolality, and urinary excretion of prostaglandin 
Over the course of vasopressin administration flow progressively 
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decreased while urinary osmolality concomitantly increased. There 
was an initial profound drop in flow from 73 ± 3 y1 per minute to 
43 ± 7 ul per minute after one day of vasopressin (p < 0.005). 
Further decreases in urine flow on days 4 and 7 were not significant 
when compared to the values on days 1 and 4. respectively. 
Urine osmolality in the absence of antidiuretic hormone was 
99 ± 8 mOsm per kg. Throughout the period of vasopressin administra¬ 
tion there was continually statistically significant increments in 
urine osmolality reaching 860 ± 80 mOsm per kg on day 7. 
Increases in urinary excretion of prostaglandin E£ paralleled 
the changes in urine osmolality with a coefficient of correlation 
equaling 0.80 (see Figure 5). Twenty-four hour urinary output of 
prostaglandin E2 after one day of vasopressin increased fourfold from 
6.9 ± 3.6 ng at baseline to 29.3 ± 4.7 ng on day 1 (p< 0.005). 
UV( 
no further change in urinary excretion of prostaglandin E2 on day 7 
despite the persistent rise in urine osmolality and fall in urine 
flow. 
Creatinine clearance for nine rats was 1.16 ± 0.06 ml per 
minute. 
ipGE^ again doubled by day 4 to 61.4 ± 9.2 ng (p<0.01). There was 
Effect of dehydration alone on urine osmolality and urinary prosta¬ 
glandin E? excretion in the Brattleboro rat 
To examine if dehydration alone in the absence of antidiuretic 
hormone is sufficient to increase urinary excretion of prostaglandin 
E2, Brattleboro rats were subjected to 16 hours of water deprivation. 
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Four hours after water had been withdrawn body weight had fallen by 
5.7 0.6%. By the 16th hour of dehydration 15.5% 1.0% of initial 
body weight was lost. Average creatinine clearance for nine animals 
at the end of dehydration was 1.60 0.14 ml per minute. 
Baseline urine osmolality (108 ± 6 mOsm per kg) was consistent 
with congenital diabetes insipidus; likewise, baseline urine flow was 
96 ± 8 yl per minute. With dehydration urine osmolality rose to 
502 ± 56 mOsm per kg (p< 0.001) and flow decreased to 17 ± 1.4 u1 per 
minute (p <0.001). Twelve hour urinary excretion of prostaglandin E2 
was 7.9 ± 1.5 ng at baseline. In the dehydrated animal UVpQ^ in¬ 
creased to 23.3 ± 2.8 ng (P<0.001). 
Quantitation of urinary prostaglandin Eg by radioimmunoassay 
A typical standard curve for the radioimmunoassay of prosta¬ 
glandin E2 is depicted in Figure 6. Nonspecific binding was 4.6± 1.25 
of trace binding. The phosphosaline buffer blank in each assay dis¬ 
placed less than 0.1% of bound radioactivity and thus was consistently 
outside the limits of the standard curve. The control with 1 ng 
prostaglandin E2 in phosphosaline buffer gave 0.97 ± 0.10 ng by assay. 
Quenching was checked with each assay and remained stable at 15.9 ± 0.4%. 
Each value for urinary prostaglandin E2 was individually corrected 
for loss during extraction and chromatographic procedures; average 
recovery was 38.6 ± 1.2%. 

Discussion 
Conservation of water by the mamnalian kidney during periods 
of water deprivation or plasma hyperosmolality requires the presence 
of vasopressin and its effective action on the collecting duct in 
addition to the establishment and preservation of a hypertonic 
medullary interstitium. 
The studies here have demonstrated that in saline-expanded 
Sprague-Dawley rats dehydration is a stimulus for renal production 
and excretion of prostaglandin In normal rats, dehydration is 
a potent stimulus for the secretion of antidiuretic hormone; however, 
other substances such as catecholamines and angiotensin II, which 
themselves influence renal synthesis of prostaglandin E2J* 
are released as well. For example, acute hemorrhagic loss of 20% of 
blood volume in anesthesized dogs increased renal prostaglandin E2; 
this increase was attributed to release of angiotensin II and in¬ 
creased renal nerve activity.77* During hemorrhagic shock, sub¬ 
stances known to affect renal prostaglandin E2 such as angio¬ 
tensin,^* kinins, ^4 and norepinephrine63 are secreted in 
addition to antidiuretic hormone, thus making the change in prosta¬ 
glandin E2 excretion difficult to attribute to any single agent. 
Furthermore, we have demonstrated that marked dehydration in the 
absence of antidiuretic hormone increases urinary excretion of 
prostaglandin E2. Although it is important to note that the degree 
of dehydration which accompanied the rise in renal prostaglandin E2 
is never achieved in rats with normal antidiuretic hormone secretory 
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function, it is nevertheless impossible to conclude unequivocally 
that in vivo stimulation of endogenous antidiuretic hormone would 
result in a quantifiable and significant rise in renal synthesis and 
urinary excretion of prostaglandin E2. 
However, there is convincing in vitro evidence that prosta¬ 
glandin E2 synthesis by renomedul1 ary interstitial cells in tissue 
culture is stimulated by the presence of vasopressin In a 
recent abstract, Stein and Lifschitz reported that vasopressin ad¬ 
ministered to normal rabbits in vivo is associated with an increased 
urinary prostaglandin E2 excretion.^ Another preliminary study by 
Valtin and co-workers also found a rise in urinary excretion of 
prostaglandin E2 after exogenous vasopressin was given for two days 
AO 
to Brattleboro rats. The low doses of vasopressin administered in 
these in vivo studies still provided a higher level of the hormone 
than under normal physiological conditions of dehydration or states 
of plasma hyperosmolality. In light of these reports by other in¬ 
vestigators, our data are consistent with, but do not conclusively 
prove, the hypothesis that endogenous antidiuretic hormone in itself 
may stimulate renal production of prostaglandin E2. 
If decreased intravascular volume were the sole factor involved 
in stimulating renal synthesis of prostaglandin E2, Brattleboro rats, 
which are chronically in negative water balance and mildly volume 
contracted and have elevated plasma renin levels,^ might be expected 
to show little change in urinary excretion of prostaglandin E2 with 
exogenous vasopressin administration. However, our results indicate 
that these antidiuretic hormone-deficient rats have an acute rise in 
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urinary excretion of prostaglandin E2 one day after low dose vaso¬ 
pressin. Significantly, prostaglandin E2 excretion continues to rise 
for four days and is sustained at the new level while the rats' total 
body water is restored to normal. Frolich and colleagues have pub¬ 
lished preliminary data that shows this rise in renal production of 
prostaglandin E2 is still evident after thirty days of exogenous vaso¬ 
pressin.^ 
Although when prostaglandin E2 production is inhibited in 
conscious dogs there is no change in basal renal blood flowJ48 we 
may speculate that profound dehydration evokes an acute renal vaso¬ 
constrictor response which in turn may stimulate urinary prostaglandin 
E2 excretion. This does not preclude the possibility that prosta¬ 
glandin E2 may act at the late distal convoluted tubule and collecting 
duct to regulate the cellular action of vasopressin. In fact, both 
actions of prostaglandin E2 may be important for the optimal main¬ 
tenance of water balance. 
Since the available studies on urinary prostaglandin E2 and 
vasopressin have appeared in abstract form,48» 64, 99 tjie conditions 
for collection and storage of urine specimens prior to radioimmuno¬ 
assay are not provided. The importance of collecting blood samples 
under strict conditions to avoid prostaglandin release from platelets 
has been stressed by Dray and co-workers.44 we have systematically 
examined the conversion of prostaglandin E2 to prostaglandin ^ in 
rat urine and shown that collection at room temperature for 24 hours 
results in significant loss of prostaglandin E2. Hence, the condi¬ 
tions for collection and storage of urine specimens for radioimmuno- 
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assay of prostaglandin E2 must be strictly controlled. It is 
recommended that 24 hour urines be collected at ice-water temperature 
and subsequently stored at -20°C until assay. 
In summary, both endogenous and exogenous vasopressin stimu¬ 
lates renal production and urinary excretion of prostaglandin E2. 
However, renal prostaglandin produced in response to other stimuli 
such as dehydration may further modulate the cellular action of anti¬ 
diuretic hormone on the collecting duct in states of altered water 
balance. The importance of collecting and storing urine for radio¬ 
immunoassay of prostaglandin E2 under strictly controlled conditions 
which prevent chemical conversion of prostaglandin E2 to prostaglandin 
A2 has been demonstrated. 
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Figure 1. Prostanoic Acid 
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r Figure 2. Structures of the Prostaglandins 
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Figure 3. Pathways in the biosynthesis of PGE2 from arachidonic acid. 

% 
C
on
ve
rs
io
n 
PG
E 
-55- 
401 
CXI 
<c 
CD 
D_ 
t 
eg 
30 _ 
Room temperature (22±3°C) a—a Control n • 
Refrigerator temperature (4°C) x—x Control #2 (urine pH 3.0) a 
Freezer temperature (-20°C) o-o 
Figure 4. Effects of Storage Temperature and Time on tne Stability of 
Prostaglandin E2 in Rat Urine. 

56 
(*<M fr2/6d) 
F
ig
ur
e 
5.
 
S
er
ia
l 
C
ha
ng
es
 
in
 
UQ
Sm
 
a
n
d 
U
V
pQ
^ 
du
ri
ng
 
7 
D
ay
s 
E
xo
ge
no
us
 
V
as
op
re
ss
in
 

57 
001 
gsM-°g 
x asN-a 6uipuig aoejj. go gusousd 
P
ic
og
ra
ns
 
PG
E2
 
F
ig
ur
e 
6.
 
T
yp
ic
al
 
St
an
da
rd
 
C
ur
ve
 
fo
r 
P
ro
st
ag
la
nd
in
 
E2
 
R
ad
io
im
m
un
oa
ss
ay
. 

-58- 
Table 1 
Standard Curve for Radioimmunoassay 
of Prostaglandin E2 
Standard No. Quantity PGE? 
(pg) 
Stock Solution No. Volume 
uu 
S 1 10 SS 1 10 
S 2 25 SS 1 25 
S 3 50 SS 1 50 
S 4 100 SS 2 10 
S 5 250 SS 2 25 
S 6 500 SS 2 50 
S 7 750 SS 2 75 
S 8 1000 SS 2 100 
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Table 3 
Effects of Endogenous Antidiuretic Hormone on Urine Osmolality and 
Urinary Excretion of Prostaglandin E2 
Baseline 
in the Sprague Dawley Rat. 
Post Dehydration P 
Flow (yl/min) 13±1.4 6.1±0.4 <0.005 
Osmolality (mOsm/kg H2O) 1268±70 2673±132 <0.001 
upge2 (pg/mi) 851±71 2628±298 <0.005 
UVrqe (ng/12 hr) 7.9±0.7 11.2±0.9 <0.05 
All values given ± S.E. (standard error) 
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Table 5 
Effect of Dehydration Alone on Urine Osmolality and 
Urinary Excretion of Prostaglandin E2 in the Brattleboro Rat (n=ll) 
Baseline Post Dehydration P 
Flow (yl/min) 96±8 17±1.4 <0.001 
Osmolality (mOsm/kg H2O) 108±6 502±56 <0.001 
UPGe2 (pg/ml) 143±45 1935±250 <0.001 
UVPGE2 (n9/12 hr) 7.9±1.5 23.3±2.8 <0.001 
All values given ± S.E. (standard error) 
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